GlobeImmune Relocates Corporate Headquarters

GlobeImmune Relocates Corporate Headquarters
PharmaLive.com (press release), PA - Dec 15, 2005... The Company initiated a Phase 1b trial for its second product, GI-5005, a Tarmogen for the treatment of chronic hepatitis C infection in July 2005. ...

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Finanzen.net, Germany - Jan 3, 2006... It is currentlyindicated as monotherapy for the treatment of adult patients sufferingfrom chronic hepatitis C viral infections with compensated liverdisease ...

Keryx Biopharmaceuticals, Inc. Announces Appointment of Senior ...
PR Newswire (press release), NY - Jan 4, 2006... recombinant interferon-alpha 2-b), for the treatment of malignant melanoma, hairy cell leukemia, AIDS-related Kaposi's sarcoma, chronic hepatitis C and chronic ...

Idenix Pharmaceuticals Reports Positive 4-Week Data From A Phase ...
PR Newswire (press release), NY - 8 hours ago... with pegylated interferon has the potential to substantially improve treatment efficacy compared to current therapy for chronic hepatitis C patients," said Jean ...

Valeant Pharmaceuticals Completes Acquisition of Hep-C Drug ...
Business Wire (press release), CA - Jan 3, 2006... It is currently indicated as monotherapy for the treatment of adult patients suffering from chronic hepatitis C viral infections with compensated liver disease ...